CDC25A and acute myeloid leukemia: Known for its oncogenic properties, CDC25A has been frequently observed in various cancer types, including lung cancer [14], breast cancer [15], and acute myeloid leukemia (AML) [16], and is closely associated with poor patient prognosis [17].